Ischemia-Modified Albumin as a New Biomarker in Predicting Oxidative Stress in Alopecia Areata
January 2019
in “
Turkish journal of medical sciences
”
Studysummary This study found that ischemia-modified albumin (IMA) may be a promising biomarker of oxidative stress in patients with alopecia areata, offering better potential compared to other oxidative stress markers.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
Read the full study on journals.tubitak.gov.tr →